Research News and Tips
Updated full board rosters
The UAMS IRB has updated its convened board committee rosters, effective Feb. 6, 2026. We look forward to working with our new reviewers, and extend our thanks to those are continuing to serve and who have cycled off the board. We so appreciate your support of the UAMS Human Research Protection Program.
Read moreConsent and HIPAA Auth. Form template updates
After consultation with Research Legal and the UAMS IRB Chair, language about costs related to research participation have been updated in the IRB’s informed consent template. There has also been a minor-looking but important change in the HIPAA authorization form language about how data might leave the institution if an investigator leaves UAMS before a […]
Read moreUAMS AI Policy
Artificial Intelligence tools’ use in clinical research settings is expected to grow. UAMS has an Academic Affairs Policy titled UAMS Artificial Intelligence Generative Tool Use Policy, accessible at this link. It is also available in Compliance360. Research-specific information about AI use begins at the bottom of page 4. We recommend checking this policy frequently as […]
Read moreNew FDA Guidances
The federal Food and Drug Administration has been staying busy, posting new guidances, updates, and drafts since late 2025. Colleagues at HRP Consulting Group have posted a compilation of these new releases on their website. The following will be of particular interest to our research community: Final Guidance: Enhancing Participation in Clinical Trials – Eligibility […]
Read moreWant to read more stories like these?
Institutional Review Board Members Blog
Updated full board rosters
The UAMS IRB has updated its convened board committee rosters, effective Feb. 6, 2026. We look forward to working with our new reviewers, and extend our thanks to those are continuing to serve and who have cycled off the board. We so appreciate your support of the UAMS Human Research Protection Program.
Read moreConsent and HIPAA Auth. Form template updates
After consultation with Research Legal and the UAMS IRB Chair, language about costs related to research participation have been updated in the IRB’s informed consent template. There has also been a minor-looking but important change in the HIPAA authorization form language about how data might leave the institution if an investigator leaves UAMS before a […]
Read moreUAMS AI Policy
Artificial Intelligence tools’ use in clinical research settings is expected to grow. UAMS has an Academic Affairs Policy titled UAMS Artificial Intelligence Generative Tool Use Policy, accessible at this link. It is also available in Compliance360. Research-specific information about AI use begins at the bottom of page 4. We recommend checking this policy frequently as […]
Read moreNew FDA Guidances
The federal Food and Drug Administration has been staying busy, posting new guidances, updates, and drafts since late 2025. Colleagues at HRP Consulting Group have posted a compilation of these new releases on their website. The following will be of particular interest to our research community: Final Guidance: Enhancing Participation in Clinical Trials – Eligibility […]
Read moreWant to read more stories like these?
New to Research or to the UAMS Institutional Review Board?
Hints to Get Your Studies Approved Faster
Yes, the UAMS Institutional Review Board looks at the big things when it reviews studies — are risks to subjects minimized? Are there appropriate provisions for obtaining the informed consent of subjects? etc. etc. But the little things can also slow down your study’s trek towards Institutional Review Board approval. Have you tracked your changes in […]
Read moreHow Do I Submit Something to the Institutional Review Board? FAQs
We get a lot of queries from people who are new to research asking about how to submit something to the UAMS Institutional Review Board. Here is a rundown of the most frequently asked questions related to Institutional Review Board submissions, and their responses. Does my project need Institutional Review Board review? Submit a human […]
Read more